173 related articles for article (PubMed ID: 31948925)
1. Gastric Intestinal Metaplasia (GIM): Clinical Decision Support Tool.
American Gastroenterological Association
Gastroenterology; 2020 Feb; 158(3):703. PubMed ID: 31948925
[No Abstract] [Full Text] [Related]
2. Spotlight: Gastric Intestinal Metaplasia.
Shah SC; Gupta S; Li D; Morgan D; Mustafa RA; Gawron AJ
Gastroenterology; 2020 Feb; 158(3):704. PubMed ID: 32035529
[No Abstract] [Full Text] [Related]
3. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia.
Gupta S; Li D; El Serag HB; Davitkov P; Altayar O; Sultan S; Falck-Ytter Y; Mustafa RA
Gastroenterology; 2020 Feb; 158(3):693-702. PubMed ID: 31816298
[No Abstract] [Full Text] [Related]
4. Gastric cancer prevention from the point of Helicobacter.
Balaban YH; Simşek H; Tatar G
Turk J Gastroenterol; 2014 Aug; 25(4):463-7. PubMed ID: 25254545
[No Abstract] [Full Text] [Related]
5. AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes.
Gawron AJ; Shah SC; Altayar O; Davitkov P; Morgan D; Turner K; Mustafa RA
Gastroenterology; 2020 Feb; 158(3):705-731.e5. PubMed ID: 31816300
[No Abstract] [Full Text] [Related]
6. Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice.
Shah SC; Gawron AJ; Mustafa RA; Piazuelo MB
Gastroenterology; 2020 Feb; 158(3):745-750. PubMed ID: 31887261
[No Abstract] [Full Text] [Related]
7. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.
Altayar O; Davitkov P; Shah SC; Gawron AJ; Morgan DR; Turner K; Mustafa RA
Gastroenterology; 2020 Feb; 158(3):732-744.e16. PubMed ID: 31816301
[No Abstract] [Full Text] [Related]
8. Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA.
Trieu JA; Bilal M; Saraireh H; Wang AY
Dig Dis Sci; 2019 May; 64(5):1079-1088. PubMed ID: 30771043
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.
Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH
Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori: an evolutionary perspective.
Jessurun J
Histopathology; 2021 Jan; 78(1):39-47. PubMed ID: 33382492
[TBL] [Abstract][Full Text] [Related]
12. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?
Sugano K; Moss SF; Kuipers EJ
Gastroenterology; 2023 Dec; 165(6):1352-1366.e1. PubMed ID: 37652306
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome.
Pulaski M; Dungan M; Weber M; Constantino G; Katona BW
Fam Cancer; 2024 Mar; 23(1):23-27. PubMed ID: 38291131
[TBL] [Abstract][Full Text] [Related]
15. Methylation and Expression of Nonclustered Protocadherins Encoding Genes and Risk of Precancerous Gastric Lesions in a High-Risk Population.
Wu S; Zhang Y; Zhang L; Ma JL; Zhou T; Li ZX; Liu WD; Li WQ; You WC; Pan KF
Cancer Prev Res (Phila); 2018 Nov; 11(11):717-726. PubMed ID: 30213786
[TBL] [Abstract][Full Text] [Related]
16. From part to whole, operative link on to endoscopic grading of gastric intestinal metaplasia, pathology to endoscopy: gastric intestinal metaplasia graded by endoscopy.
Wei N; Zhou M; Lei S; Yang L; Duan Z; Zhang Y; Zhong Z; Liu Y; Shi R
Future Oncol; 2022 Jun; 18(19):2445-2454. PubMed ID: 35574611
[No Abstract] [Full Text] [Related]
17. Controlling Gastric Cancer in a World of Heterogeneous Risk.
Huang RJ; Laszkowska M; In H; Hwang JH; Epplein M
Gastroenterology; 2023 Apr; 164(5):736-751. PubMed ID: 36706842
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
19. Gastric intestinal metaplasia: subtypes and natural history.
El-Zimaity HM; Ramchatesingh J; Saeed MA; Graham DY
J Clin Pathol; 2001 Sep; 54(9):679-83. PubMed ID: 11533073
[TBL] [Abstract][Full Text] [Related]
20. Bile reflux and bile acids in the progression of gastric intestinal metaplasia.
Qu X; Shi Y
Chin Med J (Engl); 2022 Jul; 135(14):1664-1672. PubMed ID: 35940882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
